Amaltash
Open the app
LEli Lilly & Co.
Eli Lilly & Co.LLY
Closing prices as of Aug 26, 2026Updated once daily after the US close — not a live quote.

$1,191.46

-0.88% past month

Notable price movement

  • Aug 26, 2026

    $1,189.41-3.59%

    Comparable pharmaceutical companies fell -1.35% on average, with all six peers declining . Seeking Alpha reported that the White House was set to announce new drug-pricing deals with biotechs, adding to similar agreements reached with large pharmaceutical companies earlier in the year . Seeking Alpha also reported that Eli Lilly's Zepbound cut healthcare costs in older adults in a real-world study . LLY fell more steeply than its peers on the day.

  • Aug 25, 2026

    $1,233.66-1.06%

    Comparable pharmaceutical companies rose +1.17% on average, with five of six peers gaining . LLY declined -1.06% on a day when the broader peer group moved higher, a move not shared with the cohort .

  • Aug 24, 2026

    $1,246.93-0.67%

    Seeking Alpha reported that Eli Lilly launched its oral weight loss pill Foundayo in the UK . The session traded between 1230.95 and 1262.14 on volume of 0.6x the trailing 20-session average .

  • Aug 21, 2026

    $1,255.4+0.88%

    Comparable pharmaceutical companies rose +1.55% on average, with all six peers gaining, and LLY rose alongside the cohort .

  • Aug 20, 2026

    $1,244.4-2.81%

    Comparable pharmaceutical companies fell -1.65% on average, with all six peers declining, and LLY fell alongside the cohort .

  • Aug 19, 2026

    $1,280.34+4.46%

    Comparable pharmaceutical companies rose +4.31% on average, with all six peers gaining, and LLY rose alongside the cohort . Volume on the session was 1.7x the trailing 20-session average, with the session trading between 1240.54 and 1292.65, a range of 4.2% of the low .

  • Aug 18, 2026

    $1,225.73+3.60%

    Comparable pharmaceutical companies rose +2.02% on average, with five of six peers gaining, and LLY rose alongside the cohort .

Closing prices for LLY. Summaries describe past sessions only and are not advice, a forecast or a recommendation.

Recent news

Seeking Alpha23 hours agoWall Street Lunch: Meta Settles Minors' Addiction, Data Privacy Claims For $12.7BThe Motley Fool1 day agoIs It Too Late to Buy Eli Lilly? Billionaire Ken Griffin Doesn't Think So. He Nearly Quadrupled His Stake in the Pharma Stock in Q2.Yahoo FinanceAug 17, 2026Eli Lilly and Company (LLY)'s Weight-Loss Pill Just Won Its First Race in Europe. Novo Nordisk A/S (NVO) Still Has a Head StartSeeking Alpha1 day agoWhite House is said to announce drug pricing deals with biotechsThe Motley Fool1 day agoBillionaire Stanley Druckenmiller Is Quietly Loading Up on Healthcare Stocks -- Here's What His New Positions RevealYahoo FinanceAug 16, 2026Eli Lilly's (LLY) Growth Story Keeps Adding Chapters

Headlines are published by third parties and linked as reported. Amaltash does not endorse or verify them.

Prices and financial data are historical and provided for research only. Not investment advice.